Cargando…
Meta-Analysis Reveals a Lack of Association between UGT2B17 Deletion Polymorphism and Tumor Susceptibility
PURPOSE: UGT2B17 is a vital member of the UGT2 family and functions as a detoxification enzyme which catalyzes the glucuronidation of lipophilic compounds. Accumulating evidences implicates that it may contribute to the susceptibility of tumor risk. Identification of a UGT2B17 deletion polymorphism...
Autores principales: | Deng, Xiaheng, Cheng, Yidong, Yang, Xiao, Li, Shuang, Zhao, Ruizhe, Liu, Kang, Liu, Jinliang, Cao, Qiang, Qin, Chao, Shao, Pengfei, Meng, Xiaoxin, Li, Jie, Lu, Qiang, Yin, Changjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011861/ https://www.ncbi.nlm.nih.gov/pubmed/24802609 http://dx.doi.org/10.1371/journal.pone.0096812 |
Ejemplares similares
-
GSTP1 and GSTO1 single nucleotide polymorphisms and the response of bladder cancer patients to intravesical chemotherapy
por: Deng, Xiaheng, et al.
Publicado: (2015) -
Role of the UGT2B17 deletion in exemestane pharmacogenetics
por: Luo, Shaman, et al.
Publicado: (2017) -
Association between NFKB1 −94ins/del ATTG Promoter Polymorphism and Cancer Susceptibility: An Updated Meta-Analysis
por: Yang, Xiao, et al.
Publicado: (2014) -
Lack of UGT polymorphism association with idasanutlin pharmacokinetics in solid tumor patients
por: So, W. Venus, et al.
Publicado: (2018) -
Impact of UGT2B17 gene deletion on the steroid profile of an athlete
por: Martín‐Escudero, Pilar, et al.
Publicado: (2015)